Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche

Nature

Volumn 495, Issue 7440, 2013, Pages 241-245

  Flesken Nikitin, Andrea ^a   Hwang, Chang Il ^a   Cheng, Chieh Yang ^a   Michurina, Tatyana V ^b,c   Enikolopov, Grigori ^b,c   Nikitin, Alexander Yu ^a  

^a Department of Molecular Biology and Genetics   (United States)

^b Cold Spring Harbor Laboratory ^*  (United States)

^c MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; CELL MARKER; LYMPHOID ENHANCER FACTOR 1;

CANCER; CAUSE OF DEATH; CELL ORGANELLE; PATHOGENICITY; RODENT; TRANSFORMATION; WOMENS HEALTH;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; OVARIAN SURFACE EPITHELIUM; OVARY; OVARY CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; STEM CELL; STEM CELL NICHE; TUMOR SUPPRESSOR GENE;

ANIMALS; BIOLOGICAL MARKERS; CELL LINEAGE; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; FEMALE; MALE; MICE; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; OVARY; RECEPTORS, G-PROTEIN-COUPLED; RETINOBLASTOMA PROTEIN; STEM CELL NICHE; TUMOR SUPPRESSOR PROTEIN P53;

UNITED STATES;

EID: 84874982713     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11979     Document Type: Article

References (45)

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CACancer J. Clin. 62, 10-29 (2012).
2. Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol. 177, 1053-1064 (2010).
3. Bowtell, D. D. The genesis and evolution of high-grade serous ovarian cancer. Nature Rev. Cancer 10, 803-808 (2010).
4. Visvader, J. E. Cells of origin in cancer. Nature 469, 314-322 (2011).
5. Auersperg, N. The origin of ovarian carcinomas: a unifying hypothesis. Int. J. Gynecol. Pathol. 30, 12-21 (2011).
6. Medema, J. P. & Vermeulen, L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 474, 318-326 (2011).
7. The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
8. Ahmed, A. A. et al. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J. Pathol. 221, 49-56 (2010).
9. Kurman, R. J. & Shih Ie, M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 34, 433-443 (2010).
10. Dubeau, L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 9, 1191-1197 (2008).
11. Auersperg, N., Woo, M. M. & Gilks, C. B. The origin of ovarian carcinomas: a developmental view. Gynecol. Oncol. 110, 452-454 (2008).
12. Seidman, J. D., Yemelyanova, A., Zaino, R. J. & Kurman, R. J. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int. J. Gynecol. Pathol. 30, 4-11 (2011).
13. Szotek, P. P. et al. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc. Natl Acad. Sci. USA 105, 12469-12473 (2008).
14. Blanpain, C., Horsley, V. & Fuchs, E. Epithelial stem cells: turning over new leaves. Cell 128, 445-458 (2007).
15. Simons, B. D. & Clevers, H. Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 145, 851-862 (2011).
16. Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007).
17. Storms, R. W. et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl Acad. Sci. USA 96, 9118-9123 (1999).
18. Corti, S. et al. Identification ofa primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24, 975-985 (2006).
19. Burger, P. E. et al. High aldehyde dehydrogenaseactivity:anovel functionalmarker of murine prostate stem/progenitor cells. Stem Cells 27, 2220-2228 (2009).
20. Deng, S. et al. Distinct expression levels and patternsofstem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS ONE 5, e10277 (2010).
21. Bullough, W. S. Oogenesis and its relationtothe oestrous cycle inthe adult mouse. J. Endocrinol. 3, 141-149 (1942).
22. Ji, Q. et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE 4, e6816 (2009).
23. Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Med. 17, 211-215 (2011).
24. Choi, Y. J. et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nature Cell Biol. 13, 1353-1360 (2011).
25. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007).
26. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nature Neurosci. 13, 133-140 (2010).
27. Flesken-Nikitin, A., Choi, K. C., Eng, J. P., Shmidt, E. N. & Nikitin, A. Y. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 63, 3459-3463 (2003).
28. Szabova, L. et al. Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res. 72, 4141-4153 (2012).
29. Pellegrini, G. et al. Location and clonalanalysisofstem cellsandtheir differentiated progeny in the human ocular surface. J. Cell Biol. 145, 769-782 (1999).
30. 1ve stemcells driveself-renewalinthe stomach and buildlong-lived gastric units in vitro. Cell Stem Cell 6, 25-36 (2010).
31. Corney, D. C., Flesken-Nikitin, A., Godwin, A. K., Wang, W. & Nikitin, A. Y. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 67, 8433-8438 (2007).
32. Hwang, C. I. et al. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc. Natl Acad. Sci. USA 108, 14240-14245 (2011).
33. Russo, J. E., Hauguitz, D. & Hilton, J. Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. Biochem. Pharmacol. 37, 1639-1642 (1988).
34. Lawson, D. A., Xin, L., Lukacs, R. U., Cheng, D. & Witte, O. N. Isolation and functional characterization of murine prostate stem cells. Proc. Natl Acad. Sci. USA 104, 181-186 (2007).
35. Xin, L., Lukacs, R. U., Lawson, D. A., Cheng, D. & Witte, O. N. Self-renewal and multilineage differentiation invitro from murine prostate stem cells. Stem Cells 25, 2760-2769 (2007).
36. Singec, I. et al. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nature Methods 3, 801-806 (2006).
37. Zhou, Z. et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res. 66, 7889-7898 (2006).
38. Choi, J., Curtis, S. J., Roy, D. M., Flesken-Nikitin, A. & Nikitin, A. Y. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency. Am. J. Pathol. 177, 2645-2658 (2010).
39. 1/2 mice. Genes Dev. 10, 1870-1879 (1996).
40. Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J. & Toussaint, O. Protocols to detect senescence-associated beta-galactosidase (SA-bgal) activity, a biomarker of senescent cells in culture and in vivo. Nature Protocols 4, 1798-1806 (2009).
41. Matoso, A., Zhou, Z., Hayama, R., Flesken-Nikitin, A. & Nikitin, A. Y. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis 29, 620-628 (2008).
42. Zhou, Z., Flesken-Nikitin, A. & Nikitin, A. Y. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res. 67, 5683-5690 (2007).
43. 1/2 mice. Cancer Res. 65, 787-796 (2005).
44. Rugh, R. In The Mouse: Its Reproductionand Development 7-43(Oxford Univ. Press, 1990).
45. Vermot, J., Fraulob, V., Dolle, P. & Niederreither, K. Expression of enzymes synthesizing (aldehyde dehydrogenase 1 and reinaldehyde dehydrogenase 2) and metabolizaing (Cyp26) retinoic acid in the mouse female reproductive system. Endocrinology 141, 3638-3645 (2000).